Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aravive and WuXi Biologics announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody™ platform to develop high-affinity bispecific antibodies for a target implicated in cancer and fibrosis.
read more
Themis and Merck announced the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire privately-held Themis.
read more
Lonza has announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to manufacture the drug substance for the COVID-19 Vaccine Moderna.
read more
Wednesday, December 07, 2016
Biothera Pharmaceuticals has announced an expansion of its research collaboration with Merck (known as MSD outside the United States and Canada) to include a Phase 2 clinical study investigating Biothera’s Imprime PGG in combination with KEYTRUDA® (...
read more
Datatrak has chosen to partner with Sisense to provide data visualizations, Business Intelligence dashboards, predictive analytics, and real-time reporting for users of the Datatrak Enterprise Cloud.
read more
Tuesday, September 25, 2018
Anaeropharma announced Astellas have signed a collaborative research agreement concerning the creation of novel anti-tumor drugs that utilizes characteristic features of Bifidobacterium longum.
read more
Monday, November 12, 2018
Lannett Company has entered into an agreement with Amneal Pharmaceuticals with regard to Levothyroxine Sodium Tablets USP.
read more
Wednesday, December 12, 2018
Cambrex announced it is investing $1 million at its High Point, NC site to fit out 1,300 sq. ft. of analytical laboratory space and plans to hire 9 chemical research and development scientists.
read more
Monday, December 09, 2019
Jubilant Biosys announced commencement of two expansion projects in Greater Noida and Bengaluru.
read more
ERT announced a Virtual Visit solution that enables the continuation of clinical trials during and after current global stay-at-home mandates.
read more
Wednesday, September 02, 2020
Bilim, H&T Presspart, and Hovione have unveiled a collaboration supporting Bilim’s launch into the Turkish market of Ventofor Combi Fix.
read more
Friday, December 10, 2021
Advanced Clinical, a global clinical research services organization, announced the company’s continued international expansion with the opening of a new office in Toronto, Canada.
This new subsidiary formalizes Advanced Clinical’s presence in Canada...
read more
Tuesday, February 15, 2022
National Resilience, Inc. announced a manufacturing services agreement with Takeda’s Plasma-Derived Therapies Business Unit. As part of the agreement, Resilience will focus on supporting the development and manufacture of multiple products in Takeda’...
read more
Wednesday, February 11, 2015
Pharmaceutical manufacturer Penn Pharma, a PCI company, has reached another significant safety milestone this month having operated for four years without a single accident at its facility in Tredegar, South Wales.
read more
HiFiBiO SAS has announced that the company has achieved a milestone in its research collaboration with Pfizer triggering a milestone payment to HiFiBiO.
read more